Kudos to McGill University!!!!! Advancement is what is needed for a better quality of life.
In many cases, cancer cancer can only be detected in the advanced stages and mammography is costly, subjects patient to radiation, and remains the subject of scrutiny as it's purpose is often questioned. No cure for cancer exists today, and early detection seems to have no bearing on the final outcome--as there is no cure.
However, a research team at McGill University has developed new technology that can accurately measure protein biomarkers. Scientists have worked feverishly for years trying to develop a blood test for cancer based on the presence of Carcinoembryonic Antigen, a protein biomarker for cancer identified 40 years ago. The problem is this biomarker is found in healthy individuals as well as those with cancer.
Recently a biomedical engineering group from McGill's Goodman Cancer Research Centre measured the profile of 32 proteins in the blood of 11 healthy controls and 17 individuals that had a particular subset of cancer with astonishing results.
Researchers found that a subset of six of the 32 proteins could be used to establish a fingerprint for this cancer and classify each of these patients and healthy controls as having or not having breast cancer.The end result is to develop a simple test to be given in a doctor's office with a droplet of blood.
This is positive research for many women as 1 in 8 will be diagnosed with cancer. What makes a female and male anatomically different defines what and who we are. Breast cancer is often very difficult to accept or overcome. Kudos to McGill University for working diligently towards a better quality of life for women. Cancer is a dirty word and we are no closer now than 100 years ago to a solution. This kind of research is the kind we need! When people hear about the positive results of this type of research, comfort is found.



